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Abstract NF-Y is a conserved sequence-specific transcription
factor binding to CCAAT boxes. The chromatin-associated
HMGI proteins influence promoter activities through positive
and negative effects on binding of transcription factors. It was
previously shown that HMGI(Y) synergizes the binding of NF-Y
to the K2-collagen CCAAT box [Currie, R.A. (1997) J. Biol
Chem. 272, 30880^30888]. Using recombinant proteins, we
confirm that at low concentrations of NF-Y, HMGI(Y) acts
synergistically on the K2-collagen CCAAT and we extend this
observation to HMGI and HMGI-C. However, enhancement of
DNA binding to Q-globin, K-globin and MHC class II Ea
CCAAT boxes was not observed. At high concentrations, HMGI
proteins inhibit binding to K2-collagen and to Q-globin, but not to
high affinity Ea or K-globin CCAAT. In none of our experiments
did we see a ternary complex between NF-Y, HMGI(Y) and
DNA. In protein competition experiments, NF-Y affinity was at
least two orders of magnitude higher, even in the context of the
suboptimal Q-globin CCAAT. Our data prove that HMGI
proteins have complex positive and negative effects on NF
binding to some, but not to all CCAAT boxes, suggesting that
this phenomenon is dictated by the sequences flanking the
pentanucleotide rather than direct protein-protein interactions.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The CCAAT box is a widespread element present in a vari-
ety of eukaryotic promoters. Analysis of 502 unrelated pro-
moters established that a high proportion (30%) contain the
CCAAT pentanucleotide in either the forward or reverse ori-
entation in the 360/3100 region, and identi¢ed highly pre-
ferred £anking sequences [1]. A survey of a database with 178
NF-Y binding sites showed that most eukaryotic CCAAT
boxes are indeed recognized by this activator [2]. NF-Y is a
ubiquitous heteromeric protein composed of three subunits,
NF-YA, NF-YB and NF-YC, all necessary for DNA binding
[3], whose genes have been cloned in several species (see [2] for
review). A tight association between NF-YB and NF-YC is a
prerequisite for NF-YA binding and sequence-speci¢c DNA
interactions [3] and their conserved domains contain putative
histone fold motifs [4]. This motif, composed of three K-heli-
ces separated by short loops/strand regions, enables histones
to dimerize with companion subunits, and to form the histone
octamer [5]. NF-YA also contains a conserved domain, har-
boring separable NF-YB/NF-YC and DNA binding subdo-
mains with no resemblance to known motifs [6].
The high mobility group proteins HMGI-C, HMGI and
HMGI(Y) are a family of abundant nuclear proteins associ-
ated with chromatin, that are thought to play important roles
in such diverse processes as recombination and transcription
(see [7] for review). They bind DNA in the minor groove,
recognizing AT-rich sequences via short basic domains termed
AT hooks [8]. While HMGI and HMGI(Y) are di¡erent splic-
ing products of the same gene, and therefore are collectively
named HMGI(Y), HMGI-C is encoded by a separate gene [9].
HMGI proteins were recently shown to a¡ect gene expression
by in£uencing the binding of transcription factors to their
target DNA sequences: this e¡ect is positive on some activa-
tors [10^15], but negative on homeodomain containing pro-
teins [16,17]. NF-Y was among the transcription factors
whose DNA binding and transcriptional potential was re-
ported to be increased by HMGI(Y) [15]. To extend and bet-
ter de¢ne this observation, we used recombinant NF-Y,
HMGI-C, HMGI(Y), HMGI in electrophoretic mobility shift
assays (EMSA) on several CCAAT boxes.
2. Materials and methods
2.1. Proteins production and puri¢cation
Murine HMGI cDNA was ampli¢ed and cloned in the bacterial
expression vector pAR3038, as reported for the other two, HMGI(Y)
and HMGI-C [17]. All HMGI proteins were expressed using the
BL21(DE3) Escherichia coli strain, which contains the T7 RNA poly-
merase under the lacUV5 promoter control and puri¢ed by reverse-
phase high performance liquid chromatography as previously de-
scribed [17]. The consistency between puri¢ed recombinant HMGI
proteins and calculated molecular masses from sequences was checked
by mass spectrometry (Perkin-Elmer API 1). NF-YA and NF-YB
proteins were produced from PET3b expression vectors in
BL21(DE3), as inclusion bodies according to the protocols described
previously [18]. NF-YC was produced from PET32b as a His-tagged
fusion protein. BL21(DE3) Lys S bacteria were induced and inclusion
bodies prepared, resuspended in 6 M GnCl, renatured by slow dialy-
sis, together with equimolar amounts of recombinant NF-YB and
NF-YA subunits and further puri¢ed on a NTA-agarose column
(Qiagen). All cDNAs produced by PCR were checked by sequencing
once they were introduced in the expression vectors [18].
2.2. Electrophoretic mobility shift assay (EMSA)
EMSA was performed with the indicated labelled oligonucleotides
(10 000 cpm) incubated at 20‡C for the indicated time in NF-Y bind-
ing bu¡er (50 mM KCl, 20 mM HEPES-HCl pH 7.9, 5 mM MgCl2,
1 mM dTT, glycerol 3%), or in the conditions employed in [15] (100
mM NaCl, 10 mM Tris-HCl pH 7.5, 1 mM dTT, 1 mM EDTA, 5%
glycerol). Samples were loaded on a 4.5% acrylamide 0.5UTBE gel
and run at 4‡C for 3 h at 200 V. Gels were dried on 3MM paper and
exposed.
3. Results
The recent report showing that HMGI(Y) increases the
a⁄nity of NF-Y for the K2-collagen CCAAT [15] prompted
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us to investigate its e¡ect on the proximal Q-globin CCAAT
which we have recently shown to be targeted by NF-Y [19].
This site contains a sequence overlapping the CCAAT box
(CTTGACCAATAGTCTT) potentially interacting with
HMGI proteins, which are known to require four ATs for
e⁄cient DNA binding [7]. NF-Y and HMGI proteins were
produced in bacteria and puri¢ed; HMGI proteins were
checked for purity and integrity by mass spectrometry. We
employed the K2-collagen oligonucleotide used by Currie
[15] and another one containing the proximal human Q-globin
CCAAT box in parallel EMSA experiments; the dose re-
sponse of HMGI(Y) on a ¢xed, low (0.05 ng) amount of
NF-Y is shown in Fig. 1A: without HMGI(Y), the amount
of bound NF-Y was barely detectable on K2-collagen (lane 4)
and not visible on Q-globin (lane 11). When low doses (1, 10
ng) of HMGI(Y) were added, a dramatic positive e¡ect was
seen on K2-collagen, as compared to the control BSA (com-
pare lanes 1, 2 with 4^6); on Q-globin this e¡ect was not
visible compared with the BSA control (compare lanes 8, 9
with 11^14). Consistent with the presence of four ATs, the Q-
globin site yielded a strong HMGI(Y) band at lower concen-
trations of HMGI(Y). At higher doses (100 ng) of HMGI(Y)
the NF-Y band was abolished on the K2-collagen and a very
intense faster migrating HMGI(Y) complex was predominant
(Fig. 1A, compare lanes 3 and 4^7). We performed the reverse
experiment, ¢xing the amount of HMGI(Y) at 1 ng, corre-
sponding to the dose of maximal cooperative e¡ect, and in-
creasing the concentrations of NF-Y; Fig. 1B shows that clear
synergy is visible at low doses of NF-Y only on K2-collagen,
as compared with addition of control BSA (0.05^0.2 ng, com-
pare lanes 2 and 3 with 7 and 8, respectively). At higher NF-Y
doses and on Q-globin, the e¡ect was not evident (Fig. 1B,
compare lanes 4, 5 with 9, 10; lanes 12^15 with 17^20).
NF-Y binding in these experiments was performed in the bu¡-
er indicated by Currie, which contains no MgCl2, and was
also con¢rmed in the binding conditions we routinely use
[18,19] that contain 5 mM MgCl2 (not shown). With respect
to the cited study, (i) we observed a similar positive e¡ect of
HMGI(Y), albeit at lower doses, 1 and 10 ng vs. 10^25 ng, on
suboptimal amounts of NF-Y; this behavior is speci¢c for K2-
collagen and absent on the Q-globin CCAAT. (ii) As in Cur-
rie’s study, a complex of altered mobility corresponding to
simultaneous binding of HMGI proteins and NF-Y could
not be detected under our binding and electrophoretic condi-
tions.
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Fig. 1. NF-Y and HMGI proteins binding to the K2-collagen and Q-
globin CCAAT boxes. A: EMSA dose response (1, 10, 100 ng) of
HMGI(Y) on the K2-collagen (lanes 1^7) and Q-globin (lanes 8^14)
CCAAT boxes, in the presence of a constant amount of NF-Y
(0.05 ng). NF-Y incubated alone (lanes 4, 11), with increasing
amounts (1 ng in lanes 1, 8; 10 ng in lanes 2, 9; 100 ng in lanes 3,
10) of HMGY (lanes 1^3 and 8^10), and of control BSA (lanes 5^7
and 12^14). B: EMSA dose response of NF-Y (0.05, 0.2, 0.6, 2 ng)
on the K2-collagen (lanes 1^10) and Q-globin (lanes 11^20) CCAAT
boxes in the presence of a constant amount of HMGI(Y) (1 ng).
Lanes 1 and 11: HMGI(Y) alone; lanes 6 and 16: BSA alone.
Fig. 2. Negative e¡ect of HMGI proteins at high NF-Y concentra-
tions. The K2-collagen and Q-globin CCAAT oligonucleotides were
incubated with 0.5 ng of NF-Y either alone (lane 4), with increasing
amounts (1, 10, 100 ng) of HMGI(Y) (lanes 11^13), HMGI (lanes
1^3) and HMGI-C (lanes 8^10), or control BSA (lanes 5^7).
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The previous experiments performed at low doses of NF-Y
also raised the possibility that HMGI(Y) might have a neg-
ative e¡ect on CCAAT binding. We therefore wished to com-
plete our observations with a higher amount of NF-Y (0.5 ng)
and extend them to the other HMGI and HMG-C proteins.
Fig. 2 shows that at 100 ng, HMGI(Y) almost completely
inhibited NF-Y binding both to K2-collagen and to Q-globin
CCAAT boxes (Fig. 2, lanes 3 and 4). As expected, the con-
trol BSA provoked little modi¢cation in the intensities of the
NF-Y bands. The negative e¡ect was equally evident with
comparable high amounts of HMGI and HMGI-C and with
both oligonucleotides (Fig. 2, lanes 10 and 13). Again, no
slower tertiary complex was visible at these higher NF-Y con-
centrations. We conclude that binding of HMGI proteins is
detrimental to NF-Y-CCAAT interactions, possibly because
of a mutually exclusive DNA interaction.
Both K2-collagen and Q-globin CCAAT boxes are mid-
range in terms of a⁄nity for NF-Y [19^21]; we wished to
test the e¡ect of HMGI(Y) on high a⁄nity NF-Y sites. The
K-globin and MHC class II Ea Y-box represent ideal candi-
dates, since they are both among the strongest sites (Kd
5U10311 [20,21]) yet they contain very di¡erent £anking se-
quences: the former is embedded in a GC-rich sequence
(GCCGACCAATGAGCGC), devoid of good HMGI(Y)
binding sites, while Ea is surrounded by runs of ATs
(TTTTAACCAATCAGAAAAAT) that represent candidate
sites for HMGI proteins. Firstly, we tested in EMSA the
a⁄nity of HMGI(Y) for these oligonucleotides: as expected,
the dose-response experiment shown in Fig. 3A indicates that
a nucleoprotein complex is already visible at 1 ng of
HMGI(Y) on the Ea oligonucleotide, and multiple bands
are present at 100 ng (Fig. 3A, lanes 4^6); on K-globin, a⁄n-
ity appears to be at least one order of magnitude lower (com-
pare lanes 1^3 with 4^6). Similar results were obtained with
the other HMGI proteins (data not shown). Using the labelled
K-CCAAT oligonucleotide, recombinant NF-Y was pre-incu-
bated under conditions (0.5 ng) in which 50% of the labelled
DNA was complexed with NF-Y, either alone (Fig. 3B, lane
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Fig. 3. NF-Y and HMGI proteins binding to the K-globin and MHC class II Ea Y-box. A: EMSA dose response (1, 10, 100 ng) of HMGI(Y)
on K-globin (lanes 1^3) and Ea CCAAT (lanes 4^6). B: Same as A, except that HMGI(Y) was incubated together with 0.2 ng of NF-Y on the
K-globin (lanes 1^13) and Ea Y-box (lanes 14^20). NF-Y incubated alone (lanes 7 and 17), with 1, 10, 100 ng of BSA (lanes 8^10, and 18^20,
respectively). In lanes 1^6 equivalent amounts of HMGI and HMGI-C were used.
Fig. 4. NF-Y and HMGY binding a⁄nities on the Q-globin CCAAT
box. NF-Y (0.5 ng, lanes 1^5) or HAP homology mini-NF-Y (0.5
ng, lanes 6^10) were preincubated with the labelled Q-globin
CCAAT oligonucleotide and then 0.1, 1, 10, 100 ng of HMGI(Y)
was added. In lanes 11^20, 10 ng of HMGI(Y) was preincubated
with the labelled oligo before addition of 0.1, 1, 10 and 100 ng of
NF-Y (lanes 12^15) or mini-NF-Y (lanes 17^20).
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7), together with increasing concentrations (1, 10, 100 ng) of
HMGI(Y) or with BSA control (lanes 11^13 and 8^10, respec-
tively): NF-Y binding was not substantially modi¢ed by ei-
ther incubation, but a small decrease was observed at 100 ng
concentration, when binding of the HMGI(Y) protein became
visible. We performed parallel experiments with the other
HMGI proteins and the pattern was very similar (Fig. 3B,
lanes 1^6). Note that the binding of HMGI(Y) to its target
sites was severely inhibited: 100-fold more protein was neces-
sary to obtain the same degree of HMGI(Y) binding (compare
lanes 2 in Fig. 3A and 2, 5, 12 in Fig. 3B). In parallel, we used
the Ea Y box oligo: no decrease in NF-Y binding was essen-
tially visible, while the inhibition of HMGI(Y) single and
multiple binding was extremely pronounced (compare in
Fig. 3A lanes 4^6 and in Fig. 3B, lanes 14^16). As for the
previous CCAAT boxes, no additional complex slower (or
faster) was detected on these sites. Note that unlike K2-colla-
gen, on K-globin and Ea CCAAT, low doses of HMGI pro-
teins had no e¡ect on low doses of NF-Y, a situation that
parallels the results with Q-globin (data not shown). These
data strongly suggest that binding of the two proteins is not
cooperative on these sites and indeed mutually exclusive.
To better de¢ne the relative a⁄nities of NF-Y and HMGI
proteins for overlapping sites, we performed EMSA experi-
ments changing the order of addition. Moreover, since the
slow electrophoretic mobility of wt NF-Y in our gel system
might theoretically preclude the visualization of a ternary
complex, we also used an NF-Y mutant containing only the
evolutionarily conserved domains representing the minimal
DNA binding parts of NF-Y [18]: the migration of the
mini-NF-Y is much faster and could allow the visualization
of such double binding. For these experiments, we used the Q-
globin site (best for HMGI proteins and worst for NF-Y in
terms of a⁄nity) with HMGI(Y), the HMGI protein that
showed the highest a⁄nity for DNA in our assays. We pre-
incubated 0.5 ng of either wt NF-Y (Fig. 4, lanes 1^5), or the
mini-NF-Y (Fig. 4, lanes 6^10) for 60 min, then we added
increasing concentrations of HMGI(Y) (0.1, 1, 10, 100 ng)
and pursued incubation for further 15 min. HMGY was
able to displace wt NF-Y binding only at 100 ng, whereas
for the mini-NF-Y 10 ng was su⁄cient to give a 50% inhib-
ition (compare lanes 5 and 9 in Fig. 4). The opposite experi-
ment was also performed, namely preincubation of 10 ng of
HMGI(Y) and later addition of increasing (0.1, 1, 10, 100 ng)
amounts of wt or mini-NF-Y (Fig. 4, lanes 11^15 and 16^20,
respectively) : with the wt NF-Y protein, complete inhibition
of HMGI(Y) binding was seen already at 1 ng of NF-Y, while
higher concentrations were necessary for the mini-NF-Y,
although 1 ng already yielded an NF-Y band that was more
intense than that of HMGI(Y) (Fig. 4, compares lanes 11^13
and lanes 16^20). We conclude that even within this subopti-
mal NF-Y binding site, the a⁄nity of HMGI(Y) for its target
sequence is two orders of magnitude lower than that of NF-
Y; the di¡erence with the conserved domains NF-Y mutant is
somewhat lower, but still very signi¢cant.
4. Discussion
In this report we investigated the binding of the CCAAT
transcription factor NF-Y and HMGI proteins to overlapping
DNA sequences. A previous study indicated that (i) NF-Y
binding to the K2-collagen CCAAT box is highly facilitated
by addition of HMGI(Y); (ii) overexpression of HMGI(Y) in
transfection assays modestly increases a promoter containing
multimerized CCAAT boxes (2.5-fold) and (iii) HMGI(Y) in-
teracts in solution with the C-terminal half of NF-YA [15].
Indeed we found that signi¢cant facilitation of NF-Y binding
occurs in the presence of all HMGI proteins on the K2-colla-
gen site when low amounts of HMGI and NF-Y are used, but
observed no e¡ect on K- and Q-globin and Ea CCAAT boxes
at high NF-Y concentrations. On the other hand, high con-
centrations of HMGI proteins are inhibitory of NF-Y binding
on the K2-collagen and Q-globin, but not on the K-globin and
Ea CCAAT.
Several lines of evidence indicate that NF-Y plays a pivotal
role in the activation of a wide variety of gene promoters.
Biochemical experiments have proved that NF-Y is among
the best DNA binders in terms of e⁄ciency (in the pM range)
and, despite the histone-like nature of NF-YB and NF-YC, in
terms of speci¢city as well, being able to discriminate nucleo-
tides over one turn of the double helix with the central
CCAAT as an essential core [2,20,21]. NF-Y bends and twists
DNA in a fashion that is highly reminiscent of histone-DNA
interactions [19,22]. Functional experiments in di¡erent sys-
tems have clearly established the importance of NF-Y binding
CCAAT boxes. In vitro transcription experiments suggested
that NF-Y is involved in the early phases of pre-initiation
complex formation and in re-initiation. NF-Y can help other
transcription factors (Sp1, RFX, SREBP2) bind to their target
sites and facilitates c/EBP transcriptional activation on the
albumin promoter [2]. Footprinting analysis invariably ¢nds
NF-Y binding sites of active promoters protected. Because of
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Fig. 5. Scheme of NF-Y/HMGI(Y) interactions on the di¡erent
sites. A: Sequences of the oligonucleotides used in this study; po-
tential HMGI binding sites are underlined. B: Models for NF-Y/
HMGI(Y) interactions on the three types of sites identi¢ed in this
study.
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all these features and its highly preferred position within pro-
moters, NF-Y might play an architectural role in gene activa-
tion. HMG proteins in general, and HMGI proteins in par-
ticular, are also thought to be architectural factors connecting
gene-speci¢c activators and chromatin structures. E¡orts
aimed at elucidating the e¡ect of HMGI on transcription
factor binding and activation lead to a wide spectrum of re-
sults: several promoters (TNF-L, IFN-L, IL2RK, E-selectin)
are up-regulated by cotransfections with HMGI expression
vectors, while IL4 and GP91-phox are inhibited [7]. Interest-
ingly, none of the former contain CCAAT boxes, while IL4
and GP91-phox harbor multiple NF-Y binding sites that are
crucial for transcriptional regulation [23,24]. The role of the
abundant chromatin-associated HMGI proteins might thus be
positive or negative, depending on the promoter context and
the architecture of the single activator binding sites. Consis-
tent with these observations, HMGI proteins were shown to
synergize or antagonize di¡erent transcription factors: ATF-2
and NF-UB binding and activation are positively modulated
by £anking HMGI AT-rich sites [10,11,14], while binding and
activation of homeobox proteins are inhibited by HMGI-
DNA interactions with overlapping sites [17]. We note that
NF-Y, like homeobox proteins, interacts with both the major
and the minor groove [22]. Methylation interference, IC sub-
stitutions and binding inhibition with MGBs (minor groove
binding drugs) indicate that NF-Y indeed contacts the minor
groove in the AAT sequence, which is most likely the target of
HMG-I proteins on the Q-CCAAT box oligo used here (see
Fig. 5). It is not clear at the moment whether synergy is due to
protein-protein interactions, direct binding to DNA, or indi-
rect facilitation of DNA binding. We do not favor the ¢rst
hypothesis, despite evidence that HMGI(Y) can interact with
NF-YA in solution, since in that case we would have expected
to see an e¡ect on all CCAAT boxes tested. Rather, an im-
portant conclusion of the present study is that even within the
same factor (NFY) the e¡ect of HMGI proteins depends on
the ¢ne molecular structure of the target DNA site: in gen-
eral, our results indicate that the NF-Y/HMGI interactions
are more complex than previously thought [15]. The e¡ect is
(i) synergistic on CCAAT boxes lacking an overlapping AT
stretch, such as K2-collagen, whose intermediate a⁄nity is
improved by HMGI proteins; (ii) null, even at high concen-
trations, on stronger sites, such as K-globin and Ea Y-box;
(iii) negative (at high concentrations) on sites containing an A
or T after the central CCAAT, such as Q-globin (see Fig. 5).
Note that the central CCAAT pentanucleotide is identical in
all NF-Y target sequences: the di¡erential e¡ects must there-
fore be due to the £anking sequences, which are known to
dramatically in£uence NF-Y a⁄nity [2,21,25]. It is possible
that a speci¢c subset of CCAAT boxes evolved the capacity
to coexist with HMGI sites; this is also supported by the
observation that 20% of all CCAAT boxes statistically con-
tain an A or T at the 3P [2], nucleotides determining a decrease
in NF-Y a⁄nity [21,25]. Even on sites such as the Q-globin,
however, our protein competition experiments indicate that
NF-Y has a 2 log advantage in terms of a⁄nity for a CCAAT
sequence, and probably more for an optimal CCAAT such as
the Y box. This could in theory be functionally compensated
by the physiologically higher concentrations of HMGI pro-
teins in the nucleus [7]. Whether it is indeed so, is a matter of
further investigation.
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